{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T23:15:34Z","timestamp":1792278934807,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.dld.2009.06.007","type":"journal-article","created":{"date-parts":[[2009,7,25]],"date-time":"2009-07-25T19:02:37Z","timestamp":1248548557000},"page":"287-290","source":"Crossref","is-referenced-by-count":53,"title":["Helicobacter pylori first-line treatment and rescue option containing levofloxacin in patients allergic to penicillin"],"prefix":"10.1016","volume":"42","author":[{"given":"J.P.","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"P\u00e9rez-Aisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Castro-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cosme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Moreno-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2009.06.007_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report","volume":"56","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.dld.2009.06.007_bib2","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1111\/j.1572-0241.2007.01393.x","article-title":"American College of Gastroenterology guideline on the management of Helicobacter pylori infection","volume":"102","author":"Chey","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2009.06.007_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1157\/13078424","article-title":"Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference","volume":"125","author":"Gisbert","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.dld.2009.06.007_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","article-title":"Regular review: treatment of Helicobacter pylori infection","volume":"320","author":"de Boer","year":"2000","journal-title":"BMJ"},{"issue":"Suppl. 3","key":"10.1016\/j.dld.2009.06.007_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2036.2000.00394.x","article-title":"Treatment of Helicobacter pylori: an overview","volume":"14","author":"Axon","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.2002.01276.x","article-title":"Review article: Helicobacter pylori \u201crescue\u201d regimen when proton pump inhibitor-based triple therapies fail","volume":"16","author":"Gisbert","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1523-5378.2005.00324.x","article-title":"Helicobacter pylori \u201crescue\u201d therapy after failure of two eradication treatments","volume":"10","author":"Gisbert","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib8","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1365-2036.2005.02687.x","article-title":"Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin","volume":"22","author":"Gisbert","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s10620-005-2549-1","article-title":"High eradication rates of Helicobacter pylori infection with first- and second-line combination of esomeprazole, tetracycline, and metronidazole in patients allergic to penicillin","volume":"50","author":"Rodriguez-Torres","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.dld.2009.06.007_bib10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1083-4389.2004.00195.x","article-title":"The TETRA study: a prospective evaluation of Helicobacter pylori \u2018test-and-treat\u2019 strategy on 736 patients in clinical practice","volume":"9","author":"Gisbert","year":"2004","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib11","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1046\/j.1365-2036.2000.00844.x","article-title":"Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori","volume":"14","author":"Gisbert","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib12","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0025-7753(01)71738-1","article-title":"Helicobacter pylori resistance to metronidazole and to clarithromycin in Spain. A systematic review","volume":"116","author":"Gisbert","year":"2001","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.dld.2009.06.007_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2165\/00003495-199957060-00006","article-title":"A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy","volume":"57","author":"Peitz","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2009.06.007_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1365-2036.2002.01173.x","article-title":"High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study","volume":"16","author":"Peitz","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib15","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"H. pylori antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"Megraud","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.dld.2009.06.007_bib16","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-1-7","article-title":"Efficacy of Helicobacter pylori eradication therapies: a single centre observational study","volume":"1","author":"Beales","year":"2001","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.dld.2009.06.007_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1523-5378.2005.00307.x","article-title":"Systematic review and meta-analysis: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication","volume":"10","author":"Gisbert","year":"2005","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib18","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.1999.00555.x","article-title":"A systematic review of Helicobacter pylori eradication therapy\u2014the impact of antimicrobial resistance on eradication rates","volume":"13","author":"Houben","year":"1999","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib19","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2165\/00003495-200868040-00011","article-title":"Levofloxacin: a review of its use as a high-dose, short-course treatment for bacterial infection","volume":"68","author":"Anderson","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2009.06.007_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1572-0241.2007.01500.x","article-title":"Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients","volume":"103","author":"Gisbert","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2009.06.007_bib21","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1572-0241.2006.00637.x","article-title":"Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis","volume":"101","author":"Saad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2009.06.007_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2036.2006.02737.x","article-title":"Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure","volume":"23","author":"Gisbert","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000103885","article-title":"How to proceed in Helicobacter pylori-positive chronic gastritis refractory to first- and second-line eradication therapy","volume":"25","author":"Vaira","year":"2007","journal-title":"Dig Dis"},{"key":"10.1016\/j.dld.2009.06.007_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/46.2.283","article-title":"Susceptibility of Helicobacter pylori to mupirocin, oxazolidinones, quinupristin\/dalfopristin and new quinolones","volume":"46","author":"Sanchez","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.dld.2009.06.007_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jac\/dkf055","article-title":"Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori","volume":"49","author":"Tanaka","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.dld.2009.06.007_bib26","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S1590-8658(03)00432-8","article-title":"Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy","volume":"35","author":"Watanabe","year":"2003","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2009.06.007_bib27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.0083-8703.2006.00375.x","article-title":"7-Day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity","volume":"11","author":"Antos","year":"2006","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.diagmicrobio.2005.12.003","article-title":"In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure","volume":"55","author":"Yahav","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.dld.2009.06.007_bib29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S1542-3565(04)00458-6","article-title":"A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial","volume":"2","author":"Bilardi","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2009.06.007_bib30","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2036.2005.02522.x","article-title":"A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses","volume":"22","author":"Gatta","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib31","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.dld.2005.06.002","article-title":"Levofloxacin- versus metronidazole-based rescue therapy for H. pylori infection in Japan","volume":"37","author":"Matsumoto","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.dld.2009.06.007_bib32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1046\/j.1365-2036.2000.00846.x","article-title":"Efficacy of two one-week rabeprazole\/levofloxacin-based triple therapies for Helicobacter pylori infection","volume":"14","author":"Cammarota","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2009.06.007_bib33","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00042737-200212000-00004","article-title":"Levofloxacin based regimens for the eradication of Helicobacter pylori","volume":"14","author":"Di Caro","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.dld.2009.06.007_bib34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MCG.0b013e31816d921c","article-title":"Levofloxacin, amoxicillin and omeprazole as first-line triple therapy for Helicobacter pylori eradication","volume":"43","author":"Gisbert","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.dld.2009.06.007_bib35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1523-5378.2006.00407.x","article-title":"Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole","volume":"11","author":"Marzio","year":"2006","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1523-5378.2007.00517.x","article-title":"Levofloxacin in first-line treatment of Helicobacter pylori infection","volume":"12","author":"Rispo","year":"2007","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2009.06.007_bib37","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.2165\/00003495-200363240-00008","article-title":"Levofloxacin: a review of its use in the treatment of bacterial infections in the United States","volume":"63","author":"Croom","year":"2003","journal-title":"Drugs"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865809002552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865809002552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T05:29:26Z","timestamp":1545110966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865809002552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S1590865809002552"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2009.06.007","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}